Letter to the editor: efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: a structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: There is little information about Coronavirus Disease 2019 (COVID-19) management for critically ill patients. Most of these patients develop acute respiratory distress syndrome (ARDS) due to excessive inflammatory response and the ensuing cytokine storm. Anti-inflammatory drugs including...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdolahi, Nafiseh, Kaheh, Effat, Golsha, Roghieh, Khodabakhshi, Behnaz, Norouzi, Alireza, Khandashpoor, Mahmoud, Besharat, Sima, Tavassoli, Samane, Livani, Somayeh, Azimi, Sadegh Ali, Gharib, Mohammad Hadi, Peivandi, Babak, Fazel, Abdolreza, Shirzad-Aski, Hesamaddin, Roshandel, Gholamreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303932/
https://www.ncbi.nlm.nih.gov/pubmed/32560745
http://dx.doi.org/10.1186/s13063-020-04499-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303932/
https://www.ncbi.nlm.nih.gov/pubmed/32560745
http://dx.doi.org/10.1186/s13063-020-04499-5

Ejemplares similares